Enjoy complimentary customisation on priority with our Enterprise License!
The sleep apnea implants market size is estimated to grow by USD 401,751 at a CAGR of 15.2% between 2023 and 2028. The market's growth depends on various factors, notably the rising prevalence of respiratory disorders, heightened awareness regarding the benefits of implants, and a rise in the demand for personalized treatment options and awareness of sleeping aids. With respiratory ailments becoming more prevalent, there's a growing recognition of the efficacy of implants in addressing these issues. Moreover, as patients seek tailored solutions for their conditions, the demand for personalized treatment options continues to rise. This convergence of factors underscores the market's trajectory towards expansion as it strives to meet the evolving needs of individuals grappling with respiratory health and respiratory drug challenges, thus driving the demand for respiratory drugs.
To learn more about this report, Request Free Sample
The market research and growth report extensively covers market segmentation by indication (central and obstructive), end-user (ambulatory surgical centers, hospitals, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). Furthermore, the market growth analysis report includes historic market data from 2017 to 2021. Additionally, the market is witnessing significant growth due to advancements in medical sleep apnea devices technology and increasing awareness of sleep disorders. Conditions like sleep apnea and associated symptoms such as sleepiness and breathing interruptions drive demand for innovative treatments like hypoglossal neurostimulation devices and inspire therapy. Despite high costs and government regulations, the market thrives with ongoing clinical trials and research studies to enhance efficacy and safety. The use of continuous positive airway pressure (CPAP) to reduce airway irritation devices and surgical interventions remain prominent treatments, while technological aids like sleep trackers and awareness programs promote sleep hygiene. The market anticipates further growth with advancements in implantable devices targeting moderate to severe sleep apnea, natural breathing mechanism and associated health risks such as cardiovascular conditions and depression.
The sleep apnea implants market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
The market share growth by the central sleep apnea segment will be significant during the forecast period. The brain does not send the signals needed to breathe in central cases. Also, undiagnosed or untreated central can lead to serious complications, such as heart disease, diabetes, glaucoma, cancer, and cognitive and behavioral disorders.
Get a glance at the market contribution of various segments. View the PDF Sample
The central sleep apnea segment was valued at USD 143,003.40 in 2018 and continued to grow by 2022. Additionally, the market is expected to continue growing due to the increasing prevalence, rising awareness about the condition, and the increasing availability of advanced. Furthermore, there is an increase in the number of new product launches in the market as well as better insurance coverage for the treatment. Hence, such factors drive the market growth during the forecast period.
For more insights on the market share of various regions, Download PDF Sample now!
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The rising prevalence of new product launches, the presence of key players, and favorable reimbursement policies for sleep apnea therapy are all factors that drive the regional market growth during the forecast period. Market companies focus on increasing the sales of their products by adopting business strategies, such as collaborations with local and regional players, new product launches, and the development of innovative products. This, along with the rising approvals by regulatory authorities will augment the growth of the market in North America. Hence, such factors influence the regional market growth during the forecast period.
The market is driven by the increasing prevalence of sleep-related disorders such as sleep deprivation disorders and insomnia, driving the demand for insomnia therapeutics. Obstructive sleep apnea (OSA), characterized by disrupted sleep and airway obstruction, airway irritation contributes to health-related complications and fatal accidents. Despite high costs and government regulations, demand for technological advancements like the Inspire Medical System and Assessment of OSA breathe remains strong. With a focus on improving oxygen flow and addressing peripheral complications, the market anticipates growth driven by the rising healthcare ecosystem awareness and the need for effective sleep disorder treatments with sleep masks for moderate to severe sleep breathing and helping in natural breathing mechanism. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing prevalence and respiratory disorders is a major driver for the growth of the market during the forecast period. This occurs when the upper airway is blocked repeatedly during sleep. This results in the blockage of the airflow and is known as obstructive sleep apnea (OSA). The brain does not send the signals needed to breathe in central sleep apnea cases.
Furthermore, undiagnosed or untreated can lead to serious complications, such as heart disease, diabetes, glaucoma, cancer, and cognitive and behavioural disorders. Additionally, the increased prevalence and the rising number of preterm infants have resulted in high demand. Such devices consist of headgear (straps), filters, humidifiers, tubes, masks, and nasal pillows and work by improving breathing and reducing the need for steroid treatment for the lungs and nasal and oral cavities. Hence, such factors boost sleep apnea implants market growth during the forecast period.
The rising awareness about sleep apnea is an emerging market that is expected to have a positive impact on the market growth. Good quality sleep is essential for good health and good performance, and safety at work, and OSA causes strain on the heart by repeatedly reducing oxygen levels and increasing blood pressure when patients are asleep. Severe increases the risk of developing heart problems if left untreated. The market has been witnessing significant growth in recent years, driven by the increasing prevalence of obesity and related conditions such as body mass index (BMI) imbalances, hypoxic and apneic episodes, and muscle activity disorders.
Various non-profit organizations, key companies, and government organizations are conducting awareness campaigns on disorders. For instance, key players in the market, such as Koninklijke Philips NV, ResMed Inc., Fisher, and Paykel Healthcare Corp. Ltd., are conducting promotional activities to increase awareness about sleep disorders. Hence, such factors are driving sleep apnea implants market growth during the forecast period.
The regulatory challenges in the global market are the major challenges hindering the market growth during the forecast period. The global market is highly regulated, and manufacturers must adhere to various guidelines and standards set by regulatory bodies, such as the US FDA and the EMA. A major challenge is complying with frequently changing regulations with regulatory agencies often updating and modifying their guidelines in response to new developments and emerging technologies, and manufacturers must stay up to date with these changes to avoid non-compliance issues.
Additionally, there are also challenges related to international regulations and standards. Different countries follow different requirements for regulatory approval. the requirements include Europe requiring approval from the EMA, and manufacturers must navigate a complex web of regulations and standards to sell their products in different markets. Hence, the regulatory challenges hinder sleep apnea implants market growth during the forecast period.
The sleep apnea implants market growth and forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the sleep apnea market trends and analysis report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Asahi Kasei Corp. - The company offers sleep apnea implant solutions through its subsidiary ZOLL Medical Corporation namely ZOLL Remede System.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
A prevalent sleep disorder, affecting a significant portion of the adult American population, often leads to fatal accidents and health-related complications. Chronic conditions like insomnia, jet lag, narcolepsy, and sleepwalking contribute to disturbed sleep patterns. Despite advancements, the diagnosis rate remains a challenge. Sleep centers, care facilities, and organizations like the Circadian Sleep Disorders Network, American Sleep Apnea Association (ASAA), and National Sleep Foundation play vital roles in raising awareness. Wearables with movement monitoring and heart rate capabilities offer valuable insights. Observance of events like Sleep Awareness Week promotes understanding, emphasizing the importance of addressing sleep-related disorders, especially considering their potential links to peripheral artery disease and limb ischemia.
The prevalence of sleep-related disorders like obstructive sleep apnea (OSA) continues to rise, contributing to fatal accidents and various health-related complications. To address these issues, the healthcare ecosystem has witnessed the emergence of innovative solutions such as implants like the Inspire Medical System. These implants aim to alleviate symptoms associated with disturbed sleep by restoring the natural breathing mechanism and ensuring adequate oxygen flow. However, challenges persist due to high costs and stringent government regulations, leading to peri-operative complications. Despite these restrictions, market growth is fueled by increasing demand, technological advancements, and ongoing research studies into effective treatment modalities for sleep disorders like insomnia and jet lag.
The market is witnessing substantial growth due to increasing sleep awareness programs and medical practices about sleep disorders and advancements in treatment options such as the Inspire hypoglossal nerve stimulator. Companies like Signifier Medical Technologies are pioneering innovative solutions like system to address sleep apnea disorder effectively. However, stringent government regulations and peri-operative complications pose challenges to market growth. Nonetheless, the adoption of technologies like the LivaNova aura6000 System and mini-implant assisted rapid palatal expansion (MARPE) offers promising avenues for improving OSA therapy outcomes and addressing associated health concerns like atherosclerosis, hypertension, and stroke. From palatal implants to hypoglossal nerve stimulation implants, various treatments address different aspects of sleep-related issues. Clinical studies continue to drive innovation, enhancing treatment efficacy and patient outcomes in managing sleep-related conditions. Despite the severity of these conditions, restrictions such as airway irritation persist, underscoring the need for continuous innovation and research. Through initiatives like the Investigational Device Exemption Study and publications like the Lancet Respiratory Medicine journal, the medical community strives to improve outcomes for patients and promote better sleep breathing.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
160 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 15.2% |
|
Market growth 2024-2028 |
USD 401.75 |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
12.86 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 45% |
|
Key countries |
US, Germany, France, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Advanced Brain Monitoring Inc., Asahi Kasei Corp., Avery Biomedical Devices Inc., Cleveland Medical Devices Inc., Contec Medical Systems Co. Ltd., DeVilbiss Healthcare GmbH, Fisher and Paykel Healthcare Corp. Ltd., Inspire Medical Systems Inc., Koninklijke Philips N.V., Linguaflex Inc., LivaNova PLC, Medtronic Plc, Nihon Kohden Corp., Nox Medical, Nyxoah SA, ResMed Inc., Siesta Medical Inc., SomnoMed Ltd., Somnowell Ltd., and Vyaire Medical Inc. |
|
Market dynamics |
Parent market analysis, market growth and trends, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this sleep apnea implants market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Indication
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.